These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35947491)

  • 1. Telehealth to improve continuity for patients receiving buprenorphine treatment for opioid use disorder.
    Sahu N; Chen PH; Shimoni N
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 35947491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.
    Lin LA; Fortney JC; Bohnert ASB; Coughlin LN; Zhang L; Piette JD
    J Subst Abuse Treat; 2022 Feb; 133():108492. PubMed ID: 34175175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives.
    Aronowitz SV; Engel-Rebitzer E; Dolan A; Oyekanmi K; Mandell D; Meisel Z; South E; Lowenstein M
    Harm Reduct J; 2021 Nov; 18(1):119. PubMed ID: 34823538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health center implementation of telemedicine for opioid use disorders: A qualitative assessment of adopters and nonadopters.
    Uscher-Pines L; Raja P; Mehrotra A; Huskamp HA
    J Subst Abuse Treat; 2020 Aug; 115():108037. PubMed ID: 32600625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telehealth Initiation of Buprenorphine for Opioid Use Disorder: Patient Characteristics and Outcomes.
    Nguyen B; Zhao C; Bailly E; Chi W
    J Gen Intern Med; 2024 Jan; 39(1):95-102. PubMed ID: 37670069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.
    Schramm ZA; Leroux BG; Radick AC; Ventura AS; Klein JW; Samet JH; Saxon AJ; Kim TW; Tsui JI
    Addict Sci Clin Pract; 2020 Jul; 15(1):30. PubMed ID: 32736660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine.
    Brunet N; Moore DT; Lendvai Wischik D; Mattocks KM; Rosen MI
    Subst Abus; 2022; 43(1):39-46. PubMed ID: 32078492
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Red Flags' and 'Red Tape': Telehealth and pharmacy-level barriers to buprenorphine in the United States.
    Textor L; Ventricelli D; Aronowitz SV
    Int J Drug Policy; 2022 Jul; 105():103703. PubMed ID: 35561484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth.
    Cales RH; Cales SC; Shreffler J; Huecker MR
    J Subst Abuse Treat; 2022 Feb; 133():108543. PubMed ID: 34210567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island.
    Clark SA; Davis C; Wightman RS; Wunsch C; Keeler LAJ; Reddy N; Samuels EA
    J Subst Abuse Treat; 2021 May; 124():108283. PubMed ID: 33771282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic.
    Frost MC; Zhang L; Kim HM; Lin LA
    JAMA Netw Open; 2022 Oct; 5(10):e2236298. PubMed ID: 36223118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
    Nunes EV; Levin FR; Reilly MP; El-Bassel N
    J Subst Abuse Treat; 2021 Mar; 122():108196. PubMed ID: 33221125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19.
    Poulsen MN; Santoro W; Scotti R; Henderson C; Ruddy M; Colistra A
    J Addict Med; 2023 Mar-Apr 01; 17(2):e110-e118. PubMed ID: 36129690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.
    Hughes PM; Verrastro G; Fusco CW; Wilson CG; Ostrach B
    J Rural Health; 2021 Jun; 37(3):467-472. PubMed ID: 33720447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences of Opioid Use Disorder Patients Receiving Buprenorphine Through a Telehealth Program.
    Moore DJ; Goyal D; Rodriguez L
    J Addict Nurs; 2021 Jul-Sep 01; 32(3):205-210. PubMed ID: 34473450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder.
    Lin LA; Zhang L; Kim HM; Frost MC
    Am J Psychiatry; 2022 Oct; 179(10):740-747. PubMed ID: 35899380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation.
    Wightman RS; Jacka B; Uber J; McKenzie M; Reddy NG; Winters R; Jordison Keeler LA; Samuels EA
    Am J Emerg Med; 2021 Dec; 50():409-412. PubMed ID: 34481260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.